Fig. 5. Survival analysis comparing patients receiving IBS versus no IBS during transplant. (A) Overall survival analysis (n = 68). (B) Hepatocellular carcinoma (HCC)-specific survival analysis (n = 68). (C) HCC-specific survival sub-analysis for subjects with viable tumors found on explant pathology (n = 56). The curves were compared using the log-rank test at a 95% confidence interval. IBS, intraoperative blood salvage and autotransfusion.

Int J Gastrointest Interv 2023;12:145~151 https://doi.org/10.18528/ijgii230020

© Int J Gastrointest Interv